Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about STAU1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Name | STAU1 |
| Key Genes/Proteins | MTOR, P53 |
| Related Diseases | Spinocerebellar Ataxia Type 2, Alzheimer'S Disease, Parkinson'S Disease |
Knowledge base pages for this entity
graph TD
STAU1["STAU1"]
style STAU1 fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
STAU1 -->|"interacts"| MTOR([MTOR])
STAU1 -.->|"inhibits"| Autophagy["Autophagy"]
STAU1 -.->|"biomarker for"| Spinocerebellar_Ataxia_Type_2["Spinocerebellar Ataxia Type 2"]
STAU1 -.->|"biomarker for"| Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"]
STAU1 -.->|"biomarker for"| Frontotemporal_Degeneration["Frontotemporal Degeneration"]
STAU1 -.->|"biomarker for"| Huntington_s_Disease["Huntington's Disease"]
STAU1 -.->|"biomarker for"| Alzheimer_s_Disease["Alzheimer's Disease"]
STAU1 -.->|"biomarker for"| Parkinson_s_Disease["Parkinson's Disease"]
ALS([ALS]) -.->|"protects against"| STAU1
APOPTOSIS([APOPTOSIS]) -.->|"inhibits"| STAU1
AND([AND]) -.->|"inhibits"| STAU1
NEURODEGENERATION([NEURODEGENERATION]) -->|"target for"| STAU1
C9ORF72([C9ORF72]) -->|"activates"| STAU1| Target | Relation | Type | Str |
|---|---|---|---|
| MTOR | interacts_with | gene | 0.95 |
| MTOR | upregulates | gene | 0.95 |
| Spinocerebellar Ataxia Type 2 | associated_with | disease | 0.91 |
| MTOR | regulates | gene | 0.90 |
| MTOR | activates | gene | 0.90 |
| Autophagy | inhibits | process | 0.90 |
| P53 | activates | gene | 0.90 |
| apoptosis | promotes | process | 0.90 |
| neurodegeneration | promotes | process | 0.90 |
| mTOR Translation | associated_with | process | 0.90 |
| Alzheimer'S Disease | associated_with | disease | 0.88 |
| Parkinson'S Disease | associated_with | disease | 0.88 |
| MTOR | binds | protein | 0.88 |
| Stress Granule Formation | involved_in | process | 0.85 |
| Neurodegeneration | contributes_to | process | 0.85 |
| P53 | interacts_with | gene | 0.85 |
| Neurodegeneration | targets | process | 0.85 |
| Autophagy-Lysosome Function | inhibits | pathway | 0.85 |
| KIF5 | interacts_with | protein | 0.80 |
| RNA Metabolism | mediates | process | 0.80 |
| mTOR | interacts_with | gene | 0.80 |
| mTOR | regulates | gene | 0.80 |
| neurodegeneration | implicated_in | disease | 0.80 |
| oxidative stress response | participates_in | pathway | 0.70 |
| MTOR | promotes | protein | 0.70 |
| mTOR signaling | activates | pathway | 0.70 |
| neurodegenerative diseases | associated_with | disease | 0.70 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Als | protects_against | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | associated_with | disease | 0.65 |
| Dementia | associated_with | disease | 0.65 |
| Ataxia | associated_with | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| Huntington | associated_with | disease | 0.65 |
| Neurodegeneration | causes | disease | 0.65 |
| Ataxia | therapeutic_target | disease | 0.65 |
| Frontotemporal Dementia | therapeutic_target | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Dementia | therapeutic_target | disease | 0.65 |
| STAU2 | interacts_with | protein | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Parkinson | associated_with | disease | 0.65 |
| Als | interacts_with | disease | 0.65 |
| Neurodegeneration | inhibits | disease | 0.65 |
| Spinocerebellar Ataxia | expressed_in | disease | 0.65 |
| Ataxia | expressed_in | disease | 0.65 |
| Dementia | expressed_in | disease | 0.65 |
| Frontotemporal Dementia | expressed_in | disease | 0.65 |
| Spinocerebellar Ataxia | associated_with | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| C9ORF72 | upregulates | gene | 0.85 |
| C9ORF72 | associated_with | gene | 0.80 |
| ATXN2 | associated_with | gene | 0.80 |
| ALS | protects_against | gene | 0.60 |
| APOPTOSIS | inhibits | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| NEURODEGENERATION | therapeutic_target | gene | 0.60 |
| C9ORF72 | activates | gene | 0.60 |
| MTOR | therapeutic_target | gene | 0.60 |
| C9ORF72 | therapeutic_target | gene | 0.60 |
| ALS | associated_with | gene | 0.60 |
| DEMENTIA | therapeutic_target | gene | 0.60 |
| STAU2 | associated_with | gene | 0.60 |
| ATXN2 | inhibits | gene | 0.60 |
| HUNTINGTON | associated_with | gene | 0.60 |
| MTOR | interacts_with | gene | 0.60 |
| APOPTOSIS | regulates | gene | 0.60 |
| AUTOPHAGY | associated_with | gene | 0.60 |
| ALZHEIMER | associated_with | gene | 0.60 |
| PARKINSON | associated_with | gene | 0.60 |
| DEMENTIA | expressed_in | gene | 0.60 |
| AMYOTROPHIC LATERAL SCLEROSIS | associated_with | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | associated_with | gene | 0.60 |
| RNA | expressed_in | gene | 0.60 |
| C9ORF72 | expressed_in | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| MTOR | expressed_in | gene | 0.60 |
| NEURODEGENERATION | causes | gene | 0.60 |
| ATXN2 | causes | gene | 0.60 |
| RNA | interacts_with | gene | 0.60 |
| C9ORF72 | causes | gene | 0.60 |
| AND | causes | gene | 0.60 |
| C9ORF72 | inhibits | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| RNA | regulates | gene | 0.60 |
| amyotrophic lateral sclerosis | expressed_in | gene | 0.50 |
| Neurodegenerative Diseases | expressed_in | disease | 0.50 |
| Spinal Cord | expressed_in | cell_type | 0.50 |
| disease | expressed_in | disease | 0.50 |
| NEURODEGENERATIVE DISEASE | expressed_in | concept | 0.50 |
| ALZHEIMER | expressed_in | gene | 0.50 |
| PARKINSON | expressed_in | gene | 0.50 |
| HUNTINGTON | expressed_in | gene | 0.50 |
| Ataxia | expressed_in | disease | 0.50 |
| Fibroblast | expressed_in | cell_type | 0.50 |
| Spinocerebellar Ataxia | expressed_in | disease | 0.50 |
| ALZHEIMER'S | expressed_in | concept | 0.50 |
| PARKINSON'S | expressed_in | concept | 0.50 |
| FRONTOTEMPORAL | expressed_in | concept | 0.50 |
| HUNTINGTON'S | expressed_in | concept | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||